SERDs have shown significant efficacy in treating hormone receptor-positive breast cancer, particularly in cases where patients develop resistance to other hormone therapies like aromatase inhibitors or SERMs. By effectively degrading the estrogen receptor, SERDs can overcome resistance mechanisms and provide a new line of defense against cancer progression.
